Clinical studies on MET-targeting cancer therapeutics have yielded mixed results in recent years, and MET-relevant predictive biomarkers remain elusive. New studies now reveal METex14 alternative splicing aberrations to represent potential predictive cancer genomic biomarker, hence renewing optimism and directions in the quest for optimized MET-targeting personalized cancer therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617658 | PMC |
| http://dx.doi.org/10.1158/2159-8290.CD-15-0769 | DOI Listing |
Publication Analysis
Top Keywords
cancer genomic
8
met receptor
4
receptor juxtamembrane
4
juxtamembrane exon
4
exon alternative
4
alternative spliced
4
spliced variant
4
variant novel
4
cancer
4
novel cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!